cadexgenomics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: | ||
Meta Tags
| Title | Cadex Genomics | |
| Description | Real-time therapy monitoring for patients with stage IV solid Cadex Genomics: Blood-based molecular diagnostics for cancer |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 161.35.60.200 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
cadexgenomics.com Valuation
|
US$1,036,656
Last updated: 2023-05-09 10:48:23
cadexgenomics.com has Semrush global rank of 10,210,045. cadexgenomics.com has an estimated worth of US$ 1,036,656, based on its estimated Ads revenue. cadexgenomics.com receives approximately 119,615 unique visitors each day. Its web server is located in United States, with IP address 161.35.60.200. According to SiteAdvisor, cadexgenomics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,036,656 |
| Daily Ads Revenue | US$957 |
| Monthly Ads Revenue | US$28,708 |
| Yearly Ads Revenue | US$344,489 |
| Daily Unique Visitors | 7,975 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| cadexgenomics.com. | A | 300 | IP: 161.35.60.200 |
| cadexgenomics.com. | A | 300 | IP: 64.227.12.111 |
| cadexgenomics.com. | AAAA | 299 | IPV6: 2604:a880:400:d0::182c:1001 |
| cadexgenomics.com. | AAAA | 299 | IPV6: 2600:1f18:2489:8201:d278:9378:2114:f6e5 |
| cadexgenomics.com. | NS | 3600 | NS Record: dns1.p03.nsone.net. |
| cadexgenomics.com. | NS | 3600 | NS Record: dns2.p03.nsone.net. |
| cadexgenomics.com. | NS | 3600 | NS Record: dns3.p03.nsone.net. |
| cadexgenomics.com. | NS | 3600 | NS Record: dns4.p03.nsone.net. |
| cadexgenomics.com. | MX | 3600 | MX Record: 0 cadexgenomics-com.mail.protection.outlook.com. |
| cadexgenomics.com. | TXT | 3600 | TXT Record: MS=ms93102836 |
| cadexgenomics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-09 10:48:23
| Home Technology Blog News Investors Menu Real-time therapy monitoring for patients with stage IV solid tumors Our Mission At Cadex Genomics, our mission and passion is to improve the lives of cancer patients. We develop novel, blood-based assays for patients with cancer. Over the past several years we have been working diligently to bring our first product to patients and the physicians who serve these patients. We are currently developing a new product called Alibrex, which is a blood-based assay that allows physicians to detect, in real-time, if the disease of their stage IV cancer patients is progressing. Alibrex is currently in development and will be available in 2023. Alibrex: Real-time Therapy Monitoring Under the current standard of care, it takes 3 months before an oncologist knows if a patient’s treatment is working. Alibrex is a real-time therapy monitoring system that allows oncologists to assess whether a patient’s treatment is working in just 12 days after starting |
HTTP Headers
HTTP/1.1 301 Moved Permanently cache-control: public, max-age=0, must-revalidate content-length: 41 content-type: text/plain date: Sun, 31 Oct 2021 18:01:30 GMT x-nf-request-id: 01FKBR6YAAVA04GZYDTN9HWXVC location: https://cadexgenomics.com/ server: Netlify age: 0 HTTP/2 301 cache-control: public, max-age=0, must-revalidate content-length: 45 content-type: text/plain date: Sun, 31 Oct 2021 18:01:30 GMT strict-transport-security: max-age=31536000 server: Netlify location: https://www.cadexgenomics.com/ x-nf-request-id: 01FKBR6Z1NCAF6QDK94RWR9N49 age: 0 HTTP/2 200 cache-control: public, max-age=0, must-revalidate content-type: text/html; charset=UTF-8 date: Sun, 31 Oct 2021 18:01:31 GMT etag: "58d005c767954393db778e4999a2c5a1-ssl" strict-transport-security: max-age=31536000 server: Netlify age: 0 x-nf-request-id: 01FKBR6Z8RJNNJG3TXJJ8ZFVNG content-length: 0 |
cadexgenomics.com Whois Information
Domain Name: CADEXGENOMICS.COM Registry Domain ID: 2314792594_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.namecheap.com Registrar URL: http://www.namecheap.com Updated Date: 2021-01-22T00:10:01Z Creation Date: 2018-09-27T02:43:11Z Registry Expiry Date: 2023-09-27T02:43:11Z Registrar: NameCheap, Inc. Registrar IANA ID: 1068 Registrar Abuse Contact Email: abuse@namecheap.com Registrar Abuse Contact Phone: +1.6613102107 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: DNS1.P03.NSONE.NET Name Server: DNS2.P03.NSONE.NET Name Server: DNS3.P03.NSONE.NET Name Server: DNS4.P03.NSONE.NET DNSSEC: unsigned >>> Last update of whois database: 2021-09-19T03:43:50Z <<< |